GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Continuous Remote Cardiac Arrhythmia Monitors
Devices, Players, Markets and Opportunities


About This Report

Price: US $2,850

Publication: August 2011

Product Code: CRCM811K




As  populations age, the burden of monitoring the impaired cardiac capabilities of a growing legion of patients at-risk of experiencing a cardiac event is increasingly falling to ambulatory cardiac monitors. The result has been an increase in the number of small, private companies seeking to enter the market. By combining new design initiatives, these companies are creating the next generation of mobile cardiac monitors. The current thinking in mobile cardiac monitoring incorporates a design philosophy where patient comfort and independent operation are the focus. To this end, the new generation of ambulatory cardiac monitors is benefiting from the convergence of light-weight materials, short-range device-to-device communications technology and ubiquitous, high QoS wide area networks. These new systems stress user-friendly features that include disposable sensing units, leadless data collection, and wearable gateway wireless devices for downloading cardiac event data and uploading it to an IDTF for processing and analysis.
Highlights

· Analyzes and assesses approved continuous remote cardiac monitors, their capabilities, benefits, limitations and potential

· Profiles development-stage monitors and examines their clinical status and commercial prospects

· Provides market data and sector forecasts

· Profiles market participants, their development activity and business strategies

· Evaluates the impact of economic, technology, and regulatory factors
Summary of Contents
Executive Summary

Ambulatory Cardiac Monitoring Market Dynamics
  The Business Case for Continuous Arrhythmia Monitors
  Market Segments and Demographics
  Demand Drivers
  Competitive Landscape

Mobile Cardiac Event Device Monitor Segments
  Continuous Monitoring & Transmission (Telemetry) Devices
  Competing Device Segments
    Holter Monitors
    Ambulatory Event Monitors
    Implantable Memory Loop Devices
  Key Device Design Factors
  Sensing and Event Signaling
  Caregiver Notification
  Indications and Use

Commercial Continuous Remote Monitors
  Commercial Device Assessments
    Card Guard
    PinMed
    Biomedical Systems
    CardioNet
    HeartLink II
    Corventis
    MedicALgorithmics
    Biowatch Medical

Continuously Monitor/Transmit only on Event Devices
   ScottCare
   CardioNet
   MedNet

Non-FDA Approved Devices

Development-Stage Devices

Market Factors
  Insurance/Reimbursement
  Standards and Regulations
    Healthcare Standards
    Communications Standards
  Managed Care Initiatives
  Patient Expectations

Company Profiles





 

 

Recent Research

Prefilled Syringes to 2016

Drug Self-Administration Markets to 2016

Therapeutic Proteins to 2016


Events

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career